GlassScriptPhysician profile
Daniel J Thouvenot
NPI 1881031730
$5,241.73
in general payments reported to CMS, 2019-2025
17 companies · $194 in 2025
The $194 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $602 · 2020: $516 · 2021: $631 · 2022: $2,074 · 2023: $907 · 2024: $317 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,418.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,418.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elite Orthopedics, LLC | $1,478.75 | 2019-2025 | |
| Organogenesis INC. | $1,277.58 | 2019-2025 | Puraply, Puraply Wound Matrix, Affinity |
| Stryker Corporation | $739.90 | 2019-2023 | Citrefix |
| Integra Lifesciences Corporation | $444.67 | 2019-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Kerecis Limited | $333.53 | 2021-2022 | |
| Smith+Nephew, INC. | $211.11 | 2021-2024 | Grafix Pl, Stravix Pl, Grafix Xc |
| Abbott Laboratories | $181.15 | 2020 | |
| Wright Medical Technology, INC. | $110.24 | 2019 | |
| Zimmer Biomet Holdings, INC. | $107.28 | 2020-2024 | Tapestry, Ventix, Stratum Foot Plating System |
| Paragon 28, INC. | $99.68 | 2023 | Portfolio |
| Djo, LLC | $66.68 | 2024 | Donjoy |
| Biocomposites INC | $55.59 | 2019 | |
| Bioventus LLC | $38.14 | 2024 | Exogen Ultrasound Bone Healing System |
| Veryan Medical Incorporated | $37.48 | 2021 | |
| Aroa Biosurgery Incorporated | $33.83 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $13.28 | 2023 | Krystexxa |
| Misonix INC | $12.84 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Thouvenot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.